
Vineet Laboratories Ltd is Rated Sell
2026-04-13 10:10:32Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article
Vineet Laboratories Ltd Stock Rating Upgraded to Sell Amid Mixed Financial Signals
2026-04-02 08:30:26Vineet Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, reflecting a nuanced shift in its market standing. While the company continues to grapple with weak financial fundamentals and valuation concerns, improvements in technical indicators have prompted a more favourable outlook from analysts. This article examines the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change.
Read full news article
Vineet Laboratories Ltd is Rated Strong Sell
2026-03-31 10:10:25Vineet Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Vineet Laboratories Ltd Upgraded to Sell on Mildly Bullish Technical Signals
2026-03-17 08:37:36Vineet Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap pharmaceutical company’s technical trend has improved to mildly bullish, prompting a reassessment of its outlook, even as financial performance remains flat and profitability metrics continue to disappoint.
Read full news article
Vineet Laboratories Ltd Downgraded to Strong Sell Amidst Weak Fundamentals and Technical Setbacks
2026-03-11 08:22:54Vineet Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 10 March 2026, reflecting deteriorating technical indicators and weak fundamental performance. The downgrade is driven by a combination of sideways technical trends, poor financial results, unfavourable valuation metrics, and declining quality scores, signalling heightened risk for investors in this Pharmaceuticals & Biotechnology stock.
Read full news article
Vineet Laboratories Ltd is Rated Sell
2026-03-05 10:10:53Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Vineet Laboratories Ltd is Rated Sell
2026-02-20 10:10:49Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleWhen is the next results date for Vineet Laboratories Ltd?
2026-02-11 23:17:07The next results date for Vineet Laboratories Ltd is scheduled for 14 February 2026....
Read full news article
Vineet Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Technical Signals
2026-02-09 08:20:25Vineet Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 6 February 2026, reflecting deteriorating fundamentals, challenging valuation metrics, a negative financial trend, and mixed technical signals. The pharmaceutical company’s recent performance and outlook have raised concerns among analysts, prompting a reassessment of its investment appeal.
Read full news articleClosure of Trading Window
30-Mar-2026 | Source : BSEThe Trading window for dealing in securities of the Company will remain closed from 01st April 2026 till 48 hours after announcement of Standalone Audited Financial results for the Fourth Quarter and Financial year ending on 31st March 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Feb-2026 | Source : BSEWe enclose herewith the copies of Un-audited standalone financial results of the company for the Third quarter and Nine months ended on December 31 2025 published in following Newspapers on February 16 2026 1. Financial Express (English Language) 2. Nava Telangana (Telugu Language)
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday February 14 2026 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
14-Feb-2026 | Source : BSEThe Board of Directors of the company in its meeting held today i.e. Saturday February 14 2026 has: considered and approved the unaudited standalone financial results of the company for the third quarter and nine months ended on December 31 2025 along with the Limited Review Report submitted by the Statutory Auditors. approved the proposed payments and ratified advances made to certain vendors towards Quality Control equipment and Purified RO Water equipment i.e. for the purpose(s) not mentioned in the Rights Issue Letter of Offer dated December 17 2025. However these payments made in February 2026 are for the equipment to be installed in the new production facility which was mentioned in the Letter of Offer.
Corporate Actions
No Upcoming Board Meetings
Vineet Laboratories Ltd has declared 10% dividend, ex-date: 19 Sep 22
No Splits history available
No Bonus history available
Vineet Laboratories Ltd has announced 13:12 rights issue, ex-date: 23 Dec 25






